Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs

Our aim was to identify new multi-target compounds endowed with both anti-inflammatory and anti-bacterial activities for treatment of human infections. Diflunisal, a nonsteroidal anti-inflammatory agent, has recently been repurposed for its anti-virulence properties against methicillin-resistant . E...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MedChemComm 2018-06, Vol.9 (6), p.1017-1032
Hauptverfasser: Carta, Davide, Brun, Paola, Dal Pra, Matteo, Bernabè, Giulia, Castagliuolo, Ignazio, Ferlin, Maria Grazia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1032
container_issue 6
container_start_page 1017
container_title MedChemComm
container_volume 9
creator Carta, Davide
Brun, Paola
Dal Pra, Matteo
Bernabè, Giulia
Castagliuolo, Ignazio
Ferlin, Maria Grazia
description Our aim was to identify new multi-target compounds endowed with both anti-inflammatory and anti-bacterial activities for treatment of human infections. Diflunisal, a nonsteroidal anti-inflammatory agent, has recently been repurposed for its anti-virulence properties against methicillin-resistant . Effective synthesis of some aza-analogs of the anti-inflammatory drug diflunisal was carried out following the route involving key oxazole intermediates to obtain - and -hydroxypyridinecarboxylic acid derivatives. The newly synthesized diflunisal aza-analogs did not exhibit cytotoxic activity up to 80 μM and some of them exhibited anti-inflammatory activities, decreasing the levels of pro-inflammatory cytokines and prostaglandins induced by bacterial lipopolysaccharide in human primary macrophages. Ten of the diflunisal aza-analogs were found to have interesting antibacterial activity, sensitizing , , , and to the antibacterial effects of beta-lactam antibiotics and protein synthesis inhibitors.
doi_str_mv 10.1039/c8md00139a
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6071938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2088756846</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-f38b30a2f47feefb88f6c03de04c214ce67df7d42eb448b12004baf7e0c738a23</originalsourceid><addsrcrecordid>eNpdkV1rFDEUhoMottTe-ANkwBsRRk8-dpK5EcrWj0KlF9XrcCaTdFMyyZrMFOqvN9utizY3yTnn4eU9eQl5TeEDBd5_NGoaASjv8Rk5ZiCgZStKnx_ewI_IaSm3UA9nSvXiJTniQEH1PT0mm-v7OG9s8aXBODbbbIOffMR8X-vZtz66gNOEc3rojPvugGa22WNo7B2GBWefYpNcU9Jkm9G7sERf6hR_Y4sRQ7opr8gLh6HY08f7hPz88vnH-lt7efX1Yn122Roh5Nw6rgYOyJyQzlo3KOU6A3y0IAyjwthOjk6OgtlBCDVQBiAGdNKCkVwh4yfk0153uwyTHY2Nc8agt9lPdSmd0Ov_J9Fv9E260x1I2nNVBd49CuT0a7Fl1pMvxoaA0aalaAZKyVWnRFfRt0_Q27Tkuu-OWsn6-Qx2jt7vKZNTKdm6gxkKepehXqvv5w8ZnlX4zb_2D-jfxPgfeD6ZkQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2057250202</pqid></control><display><type>article</type><title>Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs</title><source>Royal Society Of Chemistry Journals 2008-</source><source>PubMed Central</source><creator>Carta, Davide ; Brun, Paola ; Dal Pra, Matteo ; Bernabè, Giulia ; Castagliuolo, Ignazio ; Ferlin, Maria Grazia</creator><creatorcontrib>Carta, Davide ; Brun, Paola ; Dal Pra, Matteo ; Bernabè, Giulia ; Castagliuolo, Ignazio ; Ferlin, Maria Grazia</creatorcontrib><description>Our aim was to identify new multi-target compounds endowed with both anti-inflammatory and anti-bacterial activities for treatment of human infections. Diflunisal, a nonsteroidal anti-inflammatory agent, has recently been repurposed for its anti-virulence properties against methicillin-resistant . Effective synthesis of some aza-analogs of the anti-inflammatory drug diflunisal was carried out following the route involving key oxazole intermediates to obtain - and -hydroxypyridinecarboxylic acid derivatives. The newly synthesized diflunisal aza-analogs did not exhibit cytotoxic activity up to 80 μM and some of them exhibited anti-inflammatory activities, decreasing the levels of pro-inflammatory cytokines and prostaglandins induced by bacterial lipopolysaccharide in human primary macrophages. Ten of the diflunisal aza-analogs were found to have interesting antibacterial activity, sensitizing , , , and to the antibacterial effects of beta-lactam antibiotics and protein synthesis inhibitors.</description><identifier>ISSN: 2040-2503</identifier><identifier>EISSN: 2040-2511</identifier><identifier>DOI: 10.1039/c8md00139a</identifier><identifier>PMID: 30108991</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Amides ; Analogs ; Antibacterial activity ; Antibiotics ; Bacteria ; Chemistry ; Cytokines ; Cytotoxicity ; Drug resistance ; Inflammation ; Intermediates ; Lipopolysaccharides ; Macrophages ; Methicillin ; Oxazole ; Penicillin ; Prostaglandins ; Protein biosynthesis ; Protein synthesis ; Proteins ; Pseudomonas aeruginosa ; Sensitizing ; Staphylococcus infections ; Streptococcus infections ; Target recognition ; Virulence ; β-Lactam antibiotics</subject><ispartof>MedChemComm, 2018-06, Vol.9 (6), p.1017-1032</ispartof><rights>Copyright Royal Society of Chemistry 2018</rights><rights>This journal is © The Royal Society of Chemistry 2018 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-f38b30a2f47feefb88f6c03de04c214ce67df7d42eb448b12004baf7e0c738a23</citedby><cites>FETCH-LOGICAL-c447t-f38b30a2f47feefb88f6c03de04c214ce67df7d42eb448b12004baf7e0c738a23</cites><orcidid>0000-0003-0762-7933 ; 0000-0002-3279-9000</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071938/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071938/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30108991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carta, Davide</creatorcontrib><creatorcontrib>Brun, Paola</creatorcontrib><creatorcontrib>Dal Pra, Matteo</creatorcontrib><creatorcontrib>Bernabè, Giulia</creatorcontrib><creatorcontrib>Castagliuolo, Ignazio</creatorcontrib><creatorcontrib>Ferlin, Maria Grazia</creatorcontrib><title>Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs</title><title>MedChemComm</title><addtitle>Medchemcomm</addtitle><description>Our aim was to identify new multi-target compounds endowed with both anti-inflammatory and anti-bacterial activities for treatment of human infections. Diflunisal, a nonsteroidal anti-inflammatory agent, has recently been repurposed for its anti-virulence properties against methicillin-resistant . Effective synthesis of some aza-analogs of the anti-inflammatory drug diflunisal was carried out following the route involving key oxazole intermediates to obtain - and -hydroxypyridinecarboxylic acid derivatives. The newly synthesized diflunisal aza-analogs did not exhibit cytotoxic activity up to 80 μM and some of them exhibited anti-inflammatory activities, decreasing the levels of pro-inflammatory cytokines and prostaglandins induced by bacterial lipopolysaccharide in human primary macrophages. Ten of the diflunisal aza-analogs were found to have interesting antibacterial activity, sensitizing , , , and to the antibacterial effects of beta-lactam antibiotics and protein synthesis inhibitors.</description><subject>Amides</subject><subject>Analogs</subject><subject>Antibacterial activity</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Chemistry</subject><subject>Cytokines</subject><subject>Cytotoxicity</subject><subject>Drug resistance</subject><subject>Inflammation</subject><subject>Intermediates</subject><subject>Lipopolysaccharides</subject><subject>Macrophages</subject><subject>Methicillin</subject><subject>Oxazole</subject><subject>Penicillin</subject><subject>Prostaglandins</subject><subject>Protein biosynthesis</subject><subject>Protein synthesis</subject><subject>Proteins</subject><subject>Pseudomonas aeruginosa</subject><subject>Sensitizing</subject><subject>Staphylococcus infections</subject><subject>Streptococcus infections</subject><subject>Target recognition</subject><subject>Virulence</subject><subject>β-Lactam antibiotics</subject><issn>2040-2503</issn><issn>2040-2511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkV1rFDEUhoMottTe-ANkwBsRRk8-dpK5EcrWj0KlF9XrcCaTdFMyyZrMFOqvN9utizY3yTnn4eU9eQl5TeEDBd5_NGoaASjv8Rk5ZiCgZStKnx_ewI_IaSm3UA9nSvXiJTniQEH1PT0mm-v7OG9s8aXBODbbbIOffMR8X-vZtz66gNOEc3rojPvugGa22WNo7B2GBWefYpNcU9Jkm9G7sERf6hR_Y4sRQ7opr8gLh6HY08f7hPz88vnH-lt7efX1Yn122Roh5Nw6rgYOyJyQzlo3KOU6A3y0IAyjwthOjk6OgtlBCDVQBiAGdNKCkVwh4yfk0153uwyTHY2Nc8agt9lPdSmd0Ov_J9Fv9E260x1I2nNVBd49CuT0a7Fl1pMvxoaA0aalaAZKyVWnRFfRt0_Q27Tkuu-OWsn6-Qx2jt7vKZNTKdm6gxkKepehXqvv5w8ZnlX4zb_2D-jfxPgfeD6ZkQ</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Carta, Davide</creator><creator>Brun, Paola</creator><creator>Dal Pra, Matteo</creator><creator>Bernabè, Giulia</creator><creator>Castagliuolo, Ignazio</creator><creator>Ferlin, Maria Grazia</creator><general>Royal Society of Chemistry</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T5</scope><scope>7T7</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0762-7933</orcidid><orcidid>https://orcid.org/0000-0002-3279-9000</orcidid></search><sort><creationdate>20180601</creationdate><title>Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs</title><author>Carta, Davide ; Brun, Paola ; Dal Pra, Matteo ; Bernabè, Giulia ; Castagliuolo, Ignazio ; Ferlin, Maria Grazia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-f38b30a2f47feefb88f6c03de04c214ce67df7d42eb448b12004baf7e0c738a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Amides</topic><topic>Analogs</topic><topic>Antibacterial activity</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Chemistry</topic><topic>Cytokines</topic><topic>Cytotoxicity</topic><topic>Drug resistance</topic><topic>Inflammation</topic><topic>Intermediates</topic><topic>Lipopolysaccharides</topic><topic>Macrophages</topic><topic>Methicillin</topic><topic>Oxazole</topic><topic>Penicillin</topic><topic>Prostaglandins</topic><topic>Protein biosynthesis</topic><topic>Protein synthesis</topic><topic>Proteins</topic><topic>Pseudomonas aeruginosa</topic><topic>Sensitizing</topic><topic>Staphylococcus infections</topic><topic>Streptococcus infections</topic><topic>Target recognition</topic><topic>Virulence</topic><topic>β-Lactam antibiotics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carta, Davide</creatorcontrib><creatorcontrib>Brun, Paola</creatorcontrib><creatorcontrib>Dal Pra, Matteo</creatorcontrib><creatorcontrib>Bernabè, Giulia</creatorcontrib><creatorcontrib>Castagliuolo, Ignazio</creatorcontrib><creatorcontrib>Ferlin, Maria Grazia</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>MedChemComm</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carta, Davide</au><au>Brun, Paola</au><au>Dal Pra, Matteo</au><au>Bernabè, Giulia</au><au>Castagliuolo, Ignazio</au><au>Ferlin, Maria Grazia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs</atitle><jtitle>MedChemComm</jtitle><addtitle>Medchemcomm</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>9</volume><issue>6</issue><spage>1017</spage><epage>1032</epage><pages>1017-1032</pages><issn>2040-2503</issn><eissn>2040-2511</eissn><abstract>Our aim was to identify new multi-target compounds endowed with both anti-inflammatory and anti-bacterial activities for treatment of human infections. Diflunisal, a nonsteroidal anti-inflammatory agent, has recently been repurposed for its anti-virulence properties against methicillin-resistant . Effective synthesis of some aza-analogs of the anti-inflammatory drug diflunisal was carried out following the route involving key oxazole intermediates to obtain - and -hydroxypyridinecarboxylic acid derivatives. The newly synthesized diflunisal aza-analogs did not exhibit cytotoxic activity up to 80 μM and some of them exhibited anti-inflammatory activities, decreasing the levels of pro-inflammatory cytokines and prostaglandins induced by bacterial lipopolysaccharide in human primary macrophages. Ten of the diflunisal aza-analogs were found to have interesting antibacterial activity, sensitizing , , , and to the antibacterial effects of beta-lactam antibiotics and protein synthesis inhibitors.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>30108991</pmid><doi>10.1039/c8md00139a</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0003-0762-7933</orcidid><orcidid>https://orcid.org/0000-0002-3279-9000</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2040-2503
ispartof MedChemComm, 2018-06, Vol.9 (6), p.1017-1032
issn 2040-2503
2040-2511
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6071938
source Royal Society Of Chemistry Journals 2008-; PubMed Central
subjects Amides
Analogs
Antibacterial activity
Antibiotics
Bacteria
Chemistry
Cytokines
Cytotoxicity
Drug resistance
Inflammation
Intermediates
Lipopolysaccharides
Macrophages
Methicillin
Oxazole
Penicillin
Prostaglandins
Protein biosynthesis
Protein synthesis
Proteins
Pseudomonas aeruginosa
Sensitizing
Staphylococcus infections
Streptococcus infections
Target recognition
Virulence
β-Lactam antibiotics
title Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A56%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20preliminary%20anti-inflammatory%20and%20anti-bacterial%20evaluation%20of%20some%20diflunisal%20aza-analogs&rft.jtitle=MedChemComm&rft.au=Carta,%20Davide&rft.date=2018-06-01&rft.volume=9&rft.issue=6&rft.spage=1017&rft.epage=1032&rft.pages=1017-1032&rft.issn=2040-2503&rft.eissn=2040-2511&rft_id=info:doi/10.1039/c8md00139a&rft_dat=%3Cproquest_pubme%3E2088756846%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2057250202&rft_id=info:pmid/30108991&rfr_iscdi=true